IRICoR, a Centre of Excellence in Commercialization and Research specialized in drug discovery, has become a key player in the sector both nationally and internationally. IRICoR plays an increasingly pivotal role in the development of novel therapies in cancer and related areas.

The mandate of this not-for-profit organization is to facilitate and accelerate the transformation of research results into innovation for the benefit of patients. IRICoR stands out by the strategic support it provides at all stages of drug development towards commercialization of innovative therapeutic solutions.